1. Home
  2. Labeler Index
  3. Novartis Pharmaceuticals Corporation
  4. 0078-0274
  5. Product Images: Neoral

Product Images Neoral

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Neoral NDC 0078-0274 by Novartis Pharmaceuticals Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

neoral 01

neoral 01

NEORAL Soft Gelatin Capsules - modified cyclosporine capsules used for immunosuppressive agents for organ transplantation, psoriasis, and rheumatoid arthritis. The medication is produced by Novartis and comes in a package of 30 capsules. The provided information also includes the NDC number.*

chemical structure of cyclosporine - neoral 02

chemical structure of cyclosporine - neoral 02

Study 302 enrolled 299 patients with severe active RA, 99% of whom were unresponsive or intolerant to at least one prior major RA drug. Patients were randomized to 1 of 2 treatment groups (1) Neoral® and (2) cyclosporine, both of which were started at 2.5 mg/kg/day and increased after 4 weeks for inefficacy in increments of 0.5 mg/kg/day to a maximum of 5 mg/kg/day and decreased at any time for toxicity. Treatment duration was 24 weeks. The mean cyclosporine dose at the last visit was 2.91 mg/kg/day (range: 0.72-5.17) for Neoral® and 3.27 mg/kg/day (range: 0.73 5.68) for cyclosporine. - neoral 03

Study 302 enrolled 299 patients with severe active RA, 99% of whom were unresponsive or intolerant to at least one prior major RA drug. Patients were randomized to 1 of 2 treatment groups (1) Neoral® and (2) cyclosporine, both of which were started at 2.5 mg/kg/day and increased after 4 weeks for inefficacy in increments of 0.5 mg/kg/day to a maximum of 5 mg/kg/day and decreased at any time for toxicity. Treatment duration was 24 weeks. The mean cyclosporine dose at the last visit was 2.91 mg/kg/day (range: 0.72-5.17) for Neoral® and 3.27 mg/kg/day (range: 0.73 5.68) for cyclosporine. - neoral 03

PRINCIPAL DISPLAY PANEL – PACKAGE LABEL – 25 MG SOFT GELATIN CAPSULES - neoral 04

PRINCIPAL DISPLAY PANEL – PACKAGE LABEL – 25 MG SOFT GELATIN CAPSULES - neoral 04

NEORAL soft gelatin capsules are a medication containing cyclosporine used to prevent rejection of transplant, treat autoimmune diseases, and treat other conditions. The provided text also includes some identification numbers but is otherwise not readable.*

PRINCIPAL DISPLAY PANEL – PACKAGE LABEL – 100 MG SOFT GELATIN CAPSULES - neoral 05

PRINCIPAL DISPLAY PANEL – PACKAGE LABEL – 100 MG SOFT GELATIN CAPSULES - neoral 05

This text seems to be a mix of various pieces of information about a medical product, specifically the NEORAL Oral Solution by Novartis. It includes a warning about not using this solution interchangeably with other similar products without physician supervision. The text also describes the precise dosing capabilities of the solution, how it should be used, and its accurate measurement for accurate dosing. It also includes information about the manufacturer and the strength of the solution.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.